BBA
SAGE

Baker Bros. Advisors’s Sage Therapeutics SAGE Stock Holding History

Baker Bros. Advisors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-171,026
Closed -$1.86M – 96
2024
Q2 		$1.86M Sell
171,026
-236,191
-58% -$3.03M 0.02% 82
2024
Q1 		$7.63M Buy
+407,217
New +$9.39M 0.1% 56
2018
Q4 		– Sell
-567,497
Closed -$80.2M – 96
2018
Q3 		$80.2M Sell
567,497
-45,803
-7% -$7.07M 0.53% 18
2018
Q2 		$96M Sell
613,300
-33,528
-5% -$5.26M 0.72% 14
2018
Q1 		$104M Buy
646,828
+30,314
+5% +$5.15M 0.88% 14
2017
Q4 		$102M Buy
616,514
+211,029
+52% +$20.5M 0.88% 12
2017
Q3 		$25.3M Buy
405,485
+197,157
+95% +$15.5M 0.2% 33
2017
Q2 		$16.6M Hold
208,328
– – 0.15% 37
2017
Q1 		$14.8M Hold
208,328
– – 0.12% 38
2016
Q4 		$10.6M Hold
208,328
– – 0.1% 48
2016
Q3 		$9.59M Sell
208,328
-15,720
-7% -$640K 0.09% 57
2016
Q2 		$6.75M Hold
224,048
– – 0.07% 64
2016
Q1 		$7.18M Buy
224,048
+119,048
+113% +$4.19M 0.08% 65
2015
Q4 		$6.12M Hold
105,000
– – 0.05% 72
2015
Q3 		$4.44M Hold
105,000
– – 0.04% 79
2015
Q2 		$7.67M Buy
105,000
+30,000
+40% +$1.93M 0.07% 68
2015
Q1 		$3.77M Hold
75,000
– – 0.03% 83
2014
Q4 		$2.75M Hold
75,000
– – 0.03% 91
2014
Q3 		$2.36M Buy
+75,000
New +$2.17M 0.03% 85

Other funds holding SAGE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Baker Bros. Advisors's SAGE Position: Q3 2024 in Review

Baker Bros. Advisors sold out of Sage Therapeutics (SAGE) in Q3 2024, closing a stake of 171,026 shares — an estimated $1.86M sold.

Baker Bros. Advisors first reported a position in SAGE in Q3 2014 and held it in 19 quarters. The position peaked at $104M in Q1 2018. 175 funds tracked by Wall St. Rank hold SAGE as of Q3 2024.

  • Baker Bros. Advisors reported no remaining Sage Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Baker Bros. Advisors sold 171,026 Sage Therapeutics shares in Q3 2024, an estimated $1.86M.
  • Baker Bros. Advisors first reported a position in Sage Therapeutics in Q3 2014 and held it in 19 quarters.
  • Baker Bros. Advisors's Sage Therapeutics position peaked at $104M in Q1 2018.
  • 175 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2024.

Based on Baker Bros. Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.